Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL

Humoral and cellular adaptive immunity likely contribute to protection against coronavirus disease 2019 (COVID-19). Neutralizing antibodies and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells have been detected in convalescent and immunized immunocompetent individuals....

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Clare, Gaglione, Erika M, Vaughn, Lauren T, Mu, Rui, Underbayev, Chingiz, Chen, Jonathan, Pleyer, Christopher, Wiestner, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
642.Chronic Lymphocytic Leukemia: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701435/
http://dx.doi.org/10.1182/blood-2021-148887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701435/
http://dx.doi.org/10.1182/blood-2021-148887

Ejemplares similares